Related Experiment Video

Updated: Oct 30, 2025

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

10.9K

Correction: Can Plasma α-Synuclein Help Us to Differentiate Parkinson's Disease from Essential Tremor?

Silvia M Albillos1, Olimpio Montero2, Sara Calvo3

  • 1Area of Biochemistry and Molecular Biology, University of Burgos, Pza. Misael Bañuelos s/n. 09001, Burgos, ES.

Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|July 5, 2021
PubMed

Abstract:

[This corrects the article DOI: 10.5334/tohm.600.].

Keywords:
Essential tremorParkinson’s diseasealpha-synucleindiagnosisplasma biomarker

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.7K
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.4K

Related Experiment Videos

Last Updated: Oct 30, 2025

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

10.9K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.7K
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.4K

Related Concept Videos

Neural Regulation01:37

Neural Regulation

40.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.7K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

572
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
572
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

995
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
995

Articles linked to this work by shared authors, journal, and citation graph.

Gut microbiome composition in Huntington's disease: Stage-dependent differences between premanifest and manifest patients.

Life sciences·2026

Understanding Energy Expenditure: An Approach to Improving Activities of Daily Living in Huntington's Disease.

Journal of clinical medicine·2026

Decreased Physical Activity as an Early Digital Biomarker in Huntington's Disease: A One-Year Observational Study.

Brain and behavior·2026

The Feasibility and Practical Utility of Virtual Visits for Patients with Parkinson's Disease in Different World Regions.

Movement disorders clinical practice·2025

Upper Extremity Motor Performance During a Shirt Buttoning Task in Huntington's Disease.

OTJR : occupation, participation and health·2025

Prodromal, established, and advanced Parkinson's disease and atypical parkinsonisms: Prevalence and healthcare service utilization in the Catalan Health Surveillance System (Catpark study).

Parkinsonism & related disorders·2025

Lansoprazole-Induced Myoclonus.

Tremor and other hyperkinetic movements (New York, N.Y.)·2026

Botulinum Neurotoxin Treatment of Camptocormia- A Critical Review and Update.

Tremor and other hyperkinetic movements (New York, N.Y.)·2026

Prevalence of Diagnosed Essential Tremor Using Electronic Healthcare Records: A Population-Based Study in Northeast-Central Pennsylvania.

Tremor and other hyperkinetic movements (New York, N.Y.)·2026

Correction: A Case of Cala Trio-Induced Glossopharyngeal Neuralgia in a Patient with Essential Tremor and Idiopathic Parkinson's Disease.

Tremor and other hyperkinetic movements (New York, N.Y.)·2026

A Distributed Oscillatory Network Model of Parkinsonian Tremor: Integrating Basal Ganglia and Cerebello-Thalamic Circuits.

Tremor and other hyperkinetic movements (New York, N.Y.)·2026

A Case of Cala Trio-Induced Glossopharyngeal Neuralgia in a Patient with Essential Tremor and Idiopathic Parkinson's Disease.

Tremor and other hyperkinetic movements (New York, N.Y.)·2026

Carrying an unseen weight: the neuro-perceptual landscape of limb heaviness after stroke- a scoping review.

Topics in stroke rehabilitation·2026

White Matter Diffusion Anisotropy and the Effects of Inpatient Multidisciplinary Rehabilitation in Parkinson's Disease: A Diffusion Tensor Imaging Analysis.

Neurorehabilitation and neural repair·2026

Moderate-intensity treadmill exercise improved the anticonvulsant efficacy of topiramate and attenuated anxiety and depressive-like side effects in epileptic rats by upregulating 5-HT1A receptors in the hippocampus and cerebral cortex.

IBRO neuroscience reports·2026

Multi-mOdal training program to promote physical actIVity after sTrokE (MOTIVATE): Protocol for effectiveness and economic outcomes in a hybrid type 1 effectiveness-implementation randomised controlled trial.

Contemporary clinical trials·2026

Low handgrip strength is associated with impaired gait and dexterity in patients with degenerative cervical myelopathy: A cross-sectional study.

Medicine·2026

Improving the Denominator of Safety Rankings for Bicyclist and Pedestrian Safety.

Journal of urban health : bulletin of the New York Academy of Medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us